에이치엘비셀 주식회사

{
  "address": "경기도 화성시",
  "ceo_name": "이두훈",
  "certificate": [
    {
      "cert_number": "20160108629",
      "changes": "",
      "disclosure_date": "2016-07-20",
      "first_cert_date": "2016-07-20",
      "no": "1",
      "type": "연구개발유형",
      "valid_period": "2016-07-20 ~ 2018-07-19"
    },
    {
      "cert_number": "20180108812",
      "changes": "",
      "disclosure_date": "2018-07-17",
      "first_cert_date": "2016-07-20",
      "no": "2",
      "type": "연구개발유형",
      "valid_period": "2018-07-20 ~ 2020-07-19"
    },
    {
      "cert_number": "20200111159",
      "changes": "",
      "disclosure_date": "2020-08-25",
      "first_cert_date": "2016-07-20",
      "no": "3",
      "type": "연구개발유형",
      "valid_period": "2020-07-20 ~ 2022-07-19"
    },
    {
      "cert_number": "20220914020021",
      "changes": "",
      "disclosure_date": "2022-09-14",
      "first_cert_date": "2016-07-20",
      "no": "4",
      "type": "연구개발유형",
      "valid_period": "2022-07-20 ~ 2025-07-19"
    },
    {
      "cert_number": "20250916020015",
      "changes": "",
      "disclosure_date": "2025-09-16",
      "first_cert_date": "2016-07-20",
      "no": "5",
      "type": "연구개발유형",
      "valid_period": "2025-07-20 ~ 2028-07-19"
    }
  ],
  "company_name": "에이치엘비셀 주식회사",
  "corp_no": "131311-*******",
  "financials": {
    "2022": {
      "capital_stock": 16425152000,
      "cost_of_sales": 408511000,
      "current_assets": 30037875000,
      "current_liabilities": 9503791000,
      "gross_profit": -86296000,
      "net_income": -9599237000,
      "net_income_bs": -9446589000,
      "non_current_assets": 8212521000,
      "non_current_liabilities": 1018078000,
      "non_operating_expenses": 6434401000,
      "non_operating_income": 165700000,
      "operating_profit": -3330536000,
      "revenue": 322215000,
      "sga_expenses": 3244240000,
      "total_assets": 38250396000,
      "total_equity": 27728527000,
      "total_liabilities": 10521869000
    },
    "2023": {
      "capital_stock": 17233691000,
      "cost_of_sales": 1567795000,
      "current_assets": 45633307000,
      "current_liabilities": 1204155000,
      "gross_profit": -160958000,
      "net_income": 18511389000,
      "net_income_bs": 18511389000,
      "non_current_assets": 4504704000,
      "non_current_liabilities": 278516000,
      "non_operating_expenses": 5919972000,
      "non_operating_income": 27354105000,
      "operating_profit": -2922744000,
      "revenue": 1406837000,
      "sga_expenses": 2761786000,
      "total_assets": 50138011000,
      "total_equity": 48655340000,
      "total_liabilities": 1482671000
    },
    "2024": {
      "capital_stock": 17233691000,
      "cost_of_sales": 1167635000,
      "current_assets": 2547857000,
      "current_liabilities": 545478000,
      "gross_profit": 34386000,
      "net_income": 15532506000,
      "net_income_bs": 14635104000,
      "non_current_assets": 61565628000,
      "non_current_liabilities": 304843000,
      "non_operating_expenses": 312648000,
      "non_operating_income": 18971117000,
      "operating_profit": -3125963000,
      "revenue": 1202021000,
      "sga_expenses": 3160349000,
      "total_assets": 64113485000,
      "total_equity": 63263164000,
      "total_liabilities": 850321000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [],
  "main_products": "바이오인공간 개발, 간세포치료제 개발, 지혈제 개발",
  "phone": "031-372-****",
  "years": [
    2024,
    2023,
    2022
  ]
}